Anti-angiogenesis therapy and gap junction inhibition reduce MDA-MB-231 breast cancer cell invasion and metastasis in vitro and in vivo
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-angiogenesis therapy and gap junction inhibition reduce MDA-MB-231 breast cancer cell invasion and metastasis in vitro and in vivo
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-07-28
DOI
10.1038/srep12598
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Contributions of the Host Microenvironment to Cancer-Induced Bone Disease
- (2014) Sam W.Z. Olechnowicz et al. CANCER RESEARCH
- Bevacizumab-based combination therapy for advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a systematic review of the literature
- (2014) Omar Abdel-Rahman et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Role of the tumor microenvironment in the pathogenesis of gastric carcinoma
- (2014) Hye Won Chung WORLD JOURNAL OF GASTROENTEROLOGY
- The impact of bevacizumab treatment on survival and quality of life in newly diagnosed glioblastoma patients
- (2014) Hans Skovgaard Poulsen et al. Cancer Management and Research
- Mechanisms of tumor cell extravasation in an in vitro microvascular network platform
- (2013) Michelle B. Chen et al. Integrative Biology
- Pre-Treatment of Platinum Resistant Ovarian Cancer Cells with an MMP-9/MMP-2 Inhibitor Prior to Cisplatin Enhances Cytotoxicity as Determined by High Content Screening
- (2013) Alexandros Laios et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Silencing of connexin 43 suppresses invasion, migration and lung metastasis of rat hepatocellular carcinoma cells
- (2012) Kumiko Ogawa et al. CANCER SCIENCE
- Tumor angiogenesis: molecular pathways and therapeutic targets
- (2011) Sara M Weis et al. NATURE MEDICINE
- Effects of Bevacizumab on Autocrine VEGF Stimulation in Bladder Cancer Cell Lines
- (2011) Paula A. Videira et al. UROLOGIA INTERNATIONALIS
- Bevacizumab in metastatic breast cancer: when may it be used?
- (2011) Shari B. Goldfarb et al. Therapeutic Advances in Medical Oncology
- Triple-Negative Breast Cancer
- (2010) Sally Greenberg et al. CANCER JOURNAL
- Differential Effects of VEGFR-1 and VEGFR-2 Inhibition on Tumor Metastases Based on Host Organ Environment
- (2010) Y.-J. Lee et al. CANCER RESEARCH
- The gap junction proteome and its relationship to disease
- (2009) Dale W. Laird TRENDS IN CELL BIOLOGY
- Functional role of gap junctions in cytokine-induced leukocyte adhesion to endothelium in vivo
- (2008) Loreto P. Véliz et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Bone marrow-derived cells and epithelial tumours: more than just an inflammatory relationship
- (2008) Malcolm R Alison et al. CURRENT OPINION IN ONCOLOGY
- The tumor microenvironment and its contribution to tumor evolution toward metastasis
- (2008) Girieca Lorusso et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro
- (2008) Ji-Kun Li et al. WORLD JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More